ARROW CLINICAL TRIALS Trademark

Trademark Overview


On Tuesday, January 30, 2024, a trademark application was filed for ARROW CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the ARROW CLINICAL TRIALS trademark a serial number of 98382051. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Arrow Clinical Trials LLC. The ARROW CLINICAL TRIALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others
arrow clinical trials

General Information


Serial Number98382051
Word MarkARROW CLINICAL TRIALS
Filing DateTuesday, January 30, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 30, 2024
Primary Code042
First Use Anywhere DateFriday, September 2, 2022
First Use In Commerce DateFriday, September 2, 2022

Trademark Owner History


Party NameArrow Clinical Trials LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDaytona Beach, FL 32117

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2024NEW APPLICATION ENTERED
Wednesday, May 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED